MUSTANG BIO, INC. — Director's Dealing 2021

Apr 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2020-05-22

Reporting Person: Litchman Manuel MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-22	COMMON STOCK	S	4025	$3.04	Disposed	821383	Direct
2020-05-22	COMMON STOCK	S	8348	$3.04	Disposed	813035	Direct

Footnotes

F1: 4,025 shares were sold in connection with the vesting of 15,250 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2: 8,348 shares were sold in connection with the vesting of 30,500 shares on April 24, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Litchman's tax withholding obligations. Mr. Litchman had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F3: Represents the weighted average sales price.

F4: Includes restricted share units, which vest over various time periods.